Genetic Variations May Help Identify Best Candidates for Preventive Breast Cancer Drugs
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found.
Source: News from Mayo Clinic - Category: Databases & Libraries Authors: Mayo Clinic Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Databases & Libraries | Evista | Genetics | Study | Tamoxifen | Women